Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | +2.24% | +2.89% | +23.08% |
2022 | PharmChem, Inc.'s Equity Buyback announced on May 2, 2022, has cancelled. | CI |
2022 | PharmChem, Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Screening
70.1
%
| 4 | 67.2 % | 4 | 70.1 % | +7.36% |
Sweat Patch
29.9
%
| 2 | 32.8 % | 2 | 29.9 % | -5.96% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 6 | 100.0 % | +3.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Shana Veale
DFI | Director of Finance/CFO | - | 17-08-31 |
Douglas Crook
COO | Chief Operating Officer | - | 96-12-31 |
Sales & Marketing | - | - | |
Kerri Wagner
PRN | Corporate Officer/Principal | - | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Tim Eriksen
CHM | Chairman | 55 | 21-08-30 |
James Ford
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,767,331 | 4,601,254 ( 96.52 %) | 119,600 ( 2.509 %) | 96.52 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+23.08% | 14.87M | |
+68.25% | 4.32B | |
+5.67% | 2.74B | |
-2.80% | 2.62B | |
-51.24% | 1.95B | |
-19.04% | 1.67B | |
-22.51% | 1.41B | |
+16.69% | 1.2B | |
-44.81% | 1.12B | |
+16.28% | 975M |
- Stock Market
- Equities
- PCHM Stock
- Company PharmChem, Inc.